These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 26107235)
1. Secondary Circulating Tumor Cells (CTCs) but not Primary CTCs are Associated with the Clinico-Pathological Parameters in Chilean Patients With Colo-Rectal Cancer. Murray NP; Albarran V; Perez G; Villalon R; Ruiz A Asian Pac J Cancer Prev; 2015; 16(11):4745-9. PubMed ID: 26107235 [TBL] [Abstract][Full Text] [Related]
2. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Pesta M; Fichtl J; Kulda V; Topolcan O; Treska V Anticancer Res; 2013 May; 33(5):2239-43. PubMed ID: 23645782 [TBL] [Abstract][Full Text] [Related]
3. Clinico-pathological correlation of serial measurement of circulating tumor cells in 24 metastatic colorectal cancer patients receiving chemotherapy reveals interpatient heterogeneity correlated with CEA levels but independent of KRAS and BRAF mutation. Das A; Kunkel M; Joudeh J; Dicker DT; Scicchitano A; Allen JE; Sarwani N; Yang Z; Kaifi J; Zhu J; Liao J; El-Deiry WS Cancer Biol Ther; 2015; 16(5):709-13. PubMed ID: 25806877 [TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial. Jueckstock J; Rack B; Friedl TW; Scholz C; Steidl J; Trapp E; Tesch H; Forstbauer H; Lorenz R; Rezai M; Häberle L; Alunni-Fabbroni M; Schneeweiss A; Beckmann MW; Lichtenegger W; Fasching PA; Pantel K; Janni W; BMC Cancer; 2016 Jul; 16():401. PubMed ID: 27387743 [TBL] [Abstract][Full Text] [Related]
5. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application. Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872 [TBL] [Abstract][Full Text] [Related]
6. Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: results from a prospective, single-center study. Dizdar L; Fluegen G; van Dalum G; Honisch E; Neves RP; Niederacher D; Neubauer H; Fehm T; Rehders A; Krieg A; Knoefel WT; Stoecklein NH Mol Oncol; 2019 Jul; 13(7):1548-1558. PubMed ID: 31116510 [TBL] [Abstract][Full Text] [Related]
7. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study. Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593 [TBL] [Abstract][Full Text] [Related]
8. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer. Chen X; Wang X; He H; Liu Z; Hu JF; Li W PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878 [TBL] [Abstract][Full Text] [Related]
9. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis. Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050 [TBL] [Abstract][Full Text] [Related]
10. The effect of aspirin on circulating tumor cells in metastatic colorectal and breast cancer patients: a phase II trial study. Yang L; Lv Z; Xia W; Zhang W; Xin Y; Yuan H; Chen Y; Hu X; Lv Y; Xu Q; Weng X; Ni C Clin Transl Oncol; 2018 Jul; 20(7):912-921. PubMed ID: 29243075 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204 [TBL] [Abstract][Full Text] [Related]
12. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer. Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer. Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320 [TBL] [Abstract][Full Text] [Related]
14. Molecular characteristics of circulating tumor cells resemble the liver metastasis more closely than the primary tumor in metastatic colorectal cancer. Onstenk W; Sieuwerts AM; Mostert B; Lalmahomed Z; Bolt-de Vries JB; van Galen A; Smid M; Kraan J; Van M; de Weerd V; Ramírez-Moreno R; Biermann K; Verhoef C; Grünhagen DJ; IJzermans JN; Gratama JW; Martens JW; Foekens JA; Sleijfer S Oncotarget; 2016 Sep; 7(37):59058-59069. PubMed ID: 27340863 [TBL] [Abstract][Full Text] [Related]
15. The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer. Divella R; Daniele A; Abbate I; Bellizzi A; Savino E; Simone G; Giannone G; Giuliani F; Fazio V; Gadaleta-Caldarola G; Gadaleta CD; Lolli I; Sabbà C; Mazzocca A Cancer Causes Control; 2014 Nov; 25(11):1531-41. PubMed ID: 25135616 [TBL] [Abstract][Full Text] [Related]
16. Detection of circulating tumour cells may add value in endometrial cancer management. Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review. Yang C; Zou K; Zheng L; Xiong B BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932 [TBL] [Abstract][Full Text] [Related]
18. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364 [TBL] [Abstract][Full Text] [Related]
19. A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer. Barbazán J; Muinelo-Romay L; Vieito M; Candamio S; Díaz-López A; Cano A; Gómez-Tato A; Casares de Cal Mde L; Abal M; López-López R Int J Cancer; 2014 Dec; 135(11):2633-43. PubMed ID: 24752533 [TBL] [Abstract][Full Text] [Related]
20. Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer. Mu Z; Wang C; Ye Z; Austin L; Civan J; Hyslop T; Palazzo JP; Jaslow R; Li B; Myers RE; Jiang J; Xing J; Yang H; Cristofanilli M Breast Cancer Res Treat; 2015 Dec; 154(3):563-71. PubMed ID: 26573830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]